Showing results (131-140 of 569) with videos related to
Sort By:
Pageof 57
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2018
Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panelsKristy Lee, Bryce A Seifert, Hermela Shimelis, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 10, 2018
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction modelsSteven N Hart, Tanya Hoskin, Hermela Shimelis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imagingRajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.Journal of the National Cancer Institute|November 7, 2020
Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced AmenorrheaKathryn J Ruddy, Daniel J Schaid, Anthony Batzler, et al.JCO Precision Oncology|September 13, 2019
Patients' Medical and Psychosocial Experiences After Detection of a <i>CDH1</i> Variant With Multigene Panel TestingJada G Hamilton, Jessica M Long, Amanda C Brandt, et al.BJC Reports|June 3, 2026
Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studiesIsaac Allen, Nancy Whish, Siddhartha Yadav, et al.Plos One|December 1, 2022
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancerJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.NPJ Genomic Medicine|June 6, 2022
An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significanceEdwin S Iversen, Gary Lipton, Steven N Hart, et al.Journal of the National Cancer Institute|July 5, 2012
A novel automated mammographic density measure and breast cancer riskJohn J Heine, Christopher G Scott, Thomas A Sellers, et al.Cancer Research|October 31, 2012
A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activityLucia Guidugli, Vernon S Pankratz, Namit Singh, et al.Pageof 57